Federal Register Notice: FDA is establishing a public docket, Docket No. [FDA-2015-N-0030], to receive information, recommendations, and comments on matters related to its regulation of compounding of human drug products under sections 503A and 503B of the FD&C Act. This docket is intended for general comments related to human drug compounding that are not specific to documents or issues that are the subject of other dockets. To view this notice, click here.
